Earlier neopterin was demonstrated to inhibit hypoxia-induced erythropoietin synthesis in isolated perfused rat kidneys. The present experiments were performed to gain further insight into the mode of action underlying this effect. Numerous studies provided evidence of a link between neopterin and oxidative stress as well as intraccllular calcium concentrations. Thus, neopterin (200 |JM) NQS added into the perfusion medium together with either the caclium Channel blocker Verapamil (5 |iM) or the anti-oxidant N-acetylcysteine (200 pM). The addition of neopterin as a Single stimulus resulted in a significant decrease in the rate of hypoxia-induccd eryihropoietin relcase accompanied by an auginented renal vascular resistance and a reduced perfusion flow rate. Although these data point towards an involvcment of calcium and/or reacdve oxygen species, Verapamil or Nacetylcysteine were able to abrogate the suppression of erythropoietin generation which was induced by neopterin. Thercfore, the mechanisms responsible for the impact of neopterin on the production of this growih lactor in the kidney remain to be elucidated.
Pagel H. at al.\ Neopter.n anc Enthropoietin Synthesis transients in an alveolar epithelial cell line (5) , an increase in [Ca-*], in ihe human myelomonocytic cell line THP-1 in the presence of neopterin was reported by Wöll et al. (6) . These data suggest that neopterin may interfere with [Ca'*]j in a cell and tissue type-specific manner. The exact role of [Ca^*]j in EPO synthesis is still discussed controversially. Calcium ionophores were found to inhibit hypoxia-induced EPO synthesis in a Hep3B cell culture system (7), while no significant alteration in EPO generation could be found in the same model with respect to variations in (8) . To gain further insight into the potential rolc of [Ca^^Jj as a mediator of neopterin-induced suppression of EPO synthesis in our experimentai setup, rat kidneys were perfused with the calcium Channel blocker Verapamil in the presence of neopterin.
Materials and Mcthods
Kidney Perfusions The right kidneys from adult male Sprague-Dawley rats (290 ± 12 g) were perfused as described in detail elsewhere (9) . In brief, the kidneys were perfused at constant pressure (100 mmHg) in a recirculation system for 3 h. The perfusion medium was a substrateand amino acid-enriched Krebs-Henseleit buffer (pH 7.40) supplemented with pre-dialyzed (3 x 2 h) bovine serum albumin (60 g/L) and freshly drawn and washed human erythrocytes (5%). To ensure a stable Organ function during the experiments, the medium was dialyzed against a 25-fold volume of a proteinand cell-free medium. The arterial p02 was 27.9 ± 0.9 mm Hg. Neopterin (final concentration 200 pM), Verapamil (5 nM) or N-acetylcysteine (NAC, 200 fiM) were added to the perfusion medium and the dialysate. All substances were obtained from Sigma (Taufkirchen, Gerniany).
EPO measurements
EPO was measured by an enzymc-linked immunoassay in 5-fold concentrated (Centricon-lO microconcentrators; Amicon, Witten, Germany) samples of the perfusion medium. The assay was carried out according to the instructions of the manufacturer (Medac, Hamburg, Germany) except that rat serum EPO previously calibrated by bioassay was used as the Standard instead of human EPO.
Statistics
The data were nonnalized to 1 g kidney wet wcight (based on the weight of the left non-perfused kidney) and given as means ± Standard error (SEM). Dunnett's test was applied to compare a control mean wich several treatment means. P< 0.05 was considered to indicate a significant difference.
Rcsults
Fig . 1 shows the results of measurements of immunoreactive EPO in the perfusion medium of isolated rat kidneys perfused hypoxically for 180 min. The addition of neopterin to the perfusion medium (200 i-iM) resulted in a significant decrease in the rate Ol EPO production. Co-incubation with the calcium Channel blocker Verapamil (5 fiM) had no effect on the neopterin-induced suppression of EPO synthesis. Similar resulls were obtained following co-incubation with neopterin plus the antioxidant and oxygen radical scavenger NAC, (200 |aM). Tab. l summarizes renal functional parameters.
Neopterin increased renal vascular rcsistance and, hence. decrea,sed perfusion flow rate. In co-incubation experimen'.s neiiher Verapamil nor NAC affected these neopienn-induced changes. Neopterin decrcased diuresis and -to a small extcnt (not significant) -glomerular filtration rate. Both parameters were significantly higher as compared to untreated controls following co-incubation experiments with neoptcriii/vcrapamil as well as neopterin/NAC. Neilher rcabsorption rates of sodium, glucose, and water nor tubulär functions were altered by the substances used in the present cxperiments. However, as judged by the albumin excretion rate and the fractional albumin clearance, the glomerular permeabiiity t'or macromolecules was grcatly increased especially by the addition of Verapamil.
Discussion
Pathophysiological situations characterized by a chronically increased activity of the immune system, e.g. sepsis or septic shock are oftcn associated with anemia. Septic patients regularly develop anemia within a few days without evidence of severe blood loss, hemolysis or renal insufficiency (10) . One major contributor for anemia in these conditions might be an inadequate EPO response due to pro-inflammatory mcdiators that inhibit EPO formation and release. Plasma EPO and renal EPO mRNA levels were signiCicantly reduccd in rodenls f'ollowing injection of bacterial lipopolysaccharides (11, 12) . The pro-inflammaLory agonists tumor necrosis factor-a (TNF-a), interIcukin-lß (IL-Iß), and nitric oxide were shown to mhibit hypoxia-induced EPO production in HepG2 and Hep3B cells in vitro (13) (14) (15) . Comparable results were shown in the isolated perfused rat kidney model, wilh TNF-a, IL-Iß, and interleukin-6 (IL-6) being prominent suppressors of EPO release (16) .
Increased neopterin concentrations are a regulär finding during infections with viruses, parasites, and intracellular bactena. Apart from that, it is also raised in autoimmune diseases, in different types of cancer, and in the course of sepsis (2) . In several chronic disorders, neopterin concentrations were found to correlatc with the onset and the degree of anemia. The highest neopterin concentrations in cancer patients are found in those tumors with the highest incidence of ancmia. i.e. hcmatological neoplasia, ovarian . and cervical cancer (17) . In addition, inverse correlation.s have been reported between neopterin serum levels and seruni iron as well as transfemn, and a positive correlation was found between neopterin concentrations and serum femtin (17, 18) . These data support the hypothcsis that neopterin is involved in the development of anemia during chronic inflammatory diseases. Neopterin was tirst shown to affect EPO synthesis in the human hepatoma cell line HepG2 (19) . This could be confirmed in a subsequent study performed in our laboratories were addition of neopterin into the perlusate significantly reduced hypoxia-stimulated EPO generation in the isolated rat kidney (1) . The effects of neopterin on renal vascular resistence observed in the above-mentioned as well as the actual study might be due to a Stimulation of calcium flux into vascular smooth muscle cells. The rates of urine flow and glomerular filtration rate were lowered by neopterin indicating a vasoconstrictory effect in the afferent vessels of the glomerulus. In our study, changes in [Ca2+li cannot serve as an explanation for the cffects of neopterin on EPO synthesis, since calcium Channel blockade with Verapamil did not affect the reduction of hypoxia-induced EPO release following neopterin treatment.
Neopterin was shown to enhance chloramine-T and H202-mediated chemilumenscence as well as toxicity against bacteria (20) , to activate the transcription factor NF-kB with a subsequent Stimulation of INOS gene expression in vascular smooth musclc cells (21, 22) or to induce apoptosis in different cell lines (23, 24) . Since these events are mediated by oxidative stress, one may speculate that neopterin enhances oxidative mechanisms, either by up-regulating pro-oxidative mcdiators or by the consumption of anti-oxidative counterregulatory means or both. Since reactivc oxygen specics arc well-known inhibilors of EPO production (25) , it appears reasonable that oxidative stress is the mechanism of action to explain the suppressivc effects n! neopterin on EPO production. Because the anti-oxidative Compound NAC had no mtluence in our stud\. data would suggest that the influence of neopterin does not involve oxidative stress-dependent mechanisms. However, other antioxidants necd to be tested for a final conclusion.
Regarding the fact that only one antioxidant/Ca * Channel blocker has been chosen for the present experiments, a role of oxidative stress or changes in intracellular Ca'"^ concentrations cannot be exckided coinpletcly. Dctaillcd invcstigations with respect to agonists and dose-dependency are requircd to elucidate the mechanim(s) underlying the Inhibition of hypoxia-triggered EPO synthesis by neopterin .
